Earnings · US stocks

TG Therapeutics, Inc. (TGTX) earnings

TG Therapeutics, Inc. published its quarterly report on 2026-11-09: net profit +118.80% year on year. The stock moved +9.92% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-09
Net profit YoY
+118.80%
Result
Great
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+5.94%—
3 days+9.92%—
7 days+4.82%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 1 of them. The stock rose in the 3 trading days after 3 of 8 reports (average -0.31%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-11-09+118.80%0.35+35.92%+9.92%——
2026-08-03-70.60%0.05-88.60%-4.13%+3.79%+1.93%
2026-05-06+500.00%0.18-35.09%+18.73%+42.66%+40.28%
2026-02-26-6.70%0.14-57.48%-0.88%+16.76%+18.67%
2025-11-03+700.00%0.16-26.30%-2.13%-9.69%-9.49%
2025-08-04+325.00%0.17-40.85%-20.90%-9.34%-15.64%
2025-05-05—0.03-82.76%-19.77%-17.98%-24.32%
2025-03-03—0.15-12.33%+16.68%+22.00%+32.14%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: TGTX

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.